- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03047343
Evolution of Two Cohorts of Children (Univentricular and Bi-ventricular Heart) After Strapping of the Pulmonary Artery
Pulmonary artery strapping is a surgical technique aimed at providing a palliative treatment to newborns suffering from congenital heart defects, characterized by an increase in blood flow and pulmonary blood pressure.
The intervention consists of placing a band around the pulmonary artery. This band causes an artificial stenosis, therefore inducing a reduction of the pulmonary arterial pressure. It acts as a first step, preparing the ground for a future definitive repair intervention.
It is mainly used in the context of septal defects, atrio-ventricular canal defects or uni-ventricular hearts.
The complications linked to strapping include, among others, the erosion of the band in the artery lumen, its migration and the obstruction of the pulmonary artery, a pulmonary valvular insufficiency, the obstruction of the coronary artery and an ineffective strapping.
The early mortality rate of pulmonary artery strapping after 1980 varies between 1.8% and 13.6%, while strapping readjustment rates oscillate around 20%. It is assumed that the mortality is linked to the nature of the cardial malformation (uni-ventricular or bi-ventricular) rather than the procedure itself.
This retrospective study aims to evaluate the intra-hospital and extra-hospital mortality rate of pulmonary artery strapping, as well as the readjustment rate within two groups of patients: those benefiting from an uni-ventricular cardiac reparation and those benefiting from a bi-ventricular cardiac reparation. The aim is to determine the short term mortality rate of the intervention and the incidence of complications within the hospital, within the two groups.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1020
- Huderf
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients treated with pulmonary artery strapping between 2005 and 2016 at the Queen Fabiola Children Hospital
Exclusion Criteria:
- Outdated indications
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Uni-ventricular reparation
All patients treated with pulmonary artery strapping between 2005 and 2016 at the Queen Fabiola Children Hospital.
Patients benefiting from an uni-ventricular reparation.
|
Retrospective data extraction in medical files
|
|
Bi-ventricular reparation
All patients treated with pulmonary artery strapping between 2005 and 2016 at the Queen Fabiola Children Hospital.
Patients benefiting from an bi-ventricular reparation.
|
Retrospective data extraction in medical files
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Date of birth
Time Frame: 12 years
|
Date of birth of the patient
|
12 years
|
|
Sex
Time Frame: 12 years
|
Sex of the patient
|
12 years
|
|
Weight
Time Frame: 12 years
|
Weight of the patient at the time of the intervention
|
12 years
|
|
Exact diagnosis
Time Frame: 12 years
|
Exact diagnosis at the time of the intervention
|
12 years
|
|
Exact date of intervention
Time Frame: 12 years
|
Exact calender date of intervention
|
12 years
|
|
Total number of interventions
Time Frame: 12 years
|
Total number of interventions
|
12 years
|
|
SpO2
Time Frame: 12 years
|
pre-surgery oxygen saturation
|
12 years
|
|
Date of death
Time Frame: 12 years
|
If applicable, date of death of the patient
|
12 years
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Pierre Wauthy, MD, CHU Brugmann
- Principal Investigator: Nicolas Bellofatto Piazza, Huderf
Publications and helpful links
General Publications
- Horowitz MD, Culpepper WS 3rd, Williams LC 3rd, Sundgaard-Riise K, Ochsner JL. Pulmonary artery banding: analysis of a 25-year experience. Ann Thorac Surg. 1989 Sep;48(3):444-50. doi: 10.1016/s0003-4975(10)62881-0.
- Pinho P, Von Oppell UO, Brink J, Hewitson J. Pulmonary artery banding: adequacy and long-term outcome. Eur J Cardiothorac Surg. 1997 Jan;11(1):105-11. doi: 10.1016/s1010-7940(96)01049-4.
- Valente AS, Mesquita F, Mejia JA, Maia IC, Maior MS, Branco KC, Pinto VC Jr, Carvalho W Jr. Pulmonary artery banding: a simple procedure? A critical analysis at a tertiary center. Rev Bras Cir Cardiovasc. 2009 Jul-Sep;24(3):327-33. doi: 10.1590/s0102-76382009000400011. English, Portuguese.
- Takayama H, Sekiguchi A, Chikada M, Noma M, Ishizawa A, Takamoto S. Mortality of pulmonary artery banding in the current era: recent mortality of PA banding. Ann Thorac Surg. 2002 Oct;74(4):1219-23; discussion 1223-4. doi: 10.1016/s0003-4975(02)03900-0.
- Yoshimura N, Yamaguchi M, Oka S, Yoshida M, Murakami H. Pulmonary artery banding still has an important role in the treatment of congenital heart disease. Ann Thorac Surg. 2005 Apr;79(4):1463; author reply 1463-4. doi: 10.1016/j.athoracsur.2003.12.113. No abstract available.
- Brooks A, Geldenhuys A, Zuhlke L, Human P, Zilla P. Pulmonary artery banding: still a valuable option in developing countries? Eur J Cardiothorac Surg. 2012 Feb;41(2):272-6. doi: 10.1016/j.ejcts.2011.05.053. Epub 2011 Dec 12.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUB-strapping
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Malformations
-
Dr. F. Köhler Chemie GmbHSuspendedCongenital Heart MalformationsGermany
-
University of ArkansasGenentech, Inc.CompletedArteriovenous Malformations (Extracranial)United States
-
University Health Network, TorontoWithdrawnArteriovenous MalformationsCanada
-
Centre Hospitalier Universitaire DijonCompletedAntenatal Congenital MalformationsFrance
-
Sophie HorbachIGEAUnknownVascular Malformations | Capillary MalformationsNetherlands
-
King's College Hospital NHS TrustKing's College LondonCompletedCongenital Disorders | Pulmonary Arteriovenous MalformationUnited Kingdom
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingArteriovenous MalformationsFrance
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingArteriovenous MalformationsFrance
-
Centre Hospitalier Universitaire, AmiensRecruitingArteriovenous MalformationsFrance, Belgium
-
Azienda Ospedaliera Universitaria Integrata VeronaInternational Centre of Birth DefectsUnknown
Clinical Trials on Retrospective data extraction in medical files
-
Pierre WauthyCompletedCongenital Heart DefectBelgium
-
Pierre WauthyCompletedGastroesophageal RefluxBelgium
-
Pierre WauthyCompletedCardiac InsufficiencyBelgium
-
ChirecOncodistinct; CHU Brugmann, BrusselsNot yet recruitingSolid TumorFrance, Belgium, Cyprus, Lebanon, Norway
-
Agnieszka PozdzikCompletedHypercalciuria; IdiopathicBelgium
-
Brugmann University HospitalCompleted
-
Tamas IllesCompleted
-
Brugmann University HospitalCompleted